Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to compare the rate of tear evaporation, measured with a novel evaporimeter, before and for one hour after an eye drop containing nano-sized oil droplets has been instilled.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04091581
Study type Interventional
Source University of Waterloo
Contact
Status Completed
Phase Phase 4
Start date November 21, 2019
Completion date February 6, 2020

See also
  Status Clinical Trial Phase
Completed NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Phase 4
Active, not recruiting NCT04608942 - Refractory Meibomian Gland Dysfunction and Plasma Jet N/A
Completed NCT03055897 - Tear Film Innovations iLux Safety Study N/A
Completed NCT05536661 - Impact of Tear Substitute Use on Dry Eye in Gamers. N/A
Completed NCT04658927 - Dextenza With ILUX for Treatment of MGD Phase 4
Not yet recruiting NCT04711642 - Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery Phase 3
Completed NCT03055650 - iLux Treatment for Meibomian Gland Dysfunction (MGD) N/A
Not yet recruiting NCT06158997 - Safety and Effectiveness of EyePeace on Signs and Symptoms of Dry Eye Disease N/A
Completed NCT05331924 - Quality of Life Improvement in Dry Eye Patients After Intense Pulsed Light Therapy Compared to Punctal Plugs N/A
Completed NCT04037969 - Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday N/A